Elsevier Journals, 2017
Vaccines Are Coming but They Won’t End Covid-19 Anytime Soon
In the Philippines, inoculating the necessary 60 million to 70 million people could take up to five years, officials say
By Feliz Solomon
WSJ. Dec. 13, 2020
… Soumya Swaminathan, chief scientist of the World Health Organization. She cited the hepatitis B vaccine, saying it took 30 years after its introduction in rich countries to reach low- and middle-income countries.
Professor Jonathan Van-Tam
(England’s deputy chief medical officer)
“The reality is, until we get a vaccine, and only if we get a vaccine that is really capable of suppressing disease levels, will we ever be “out of this””
“From that perspective, we may have to live, and learn to live, with this virus in the long-term. Certainly for many months to come, if not years.”
We are still at the start of this.
William Haseltine, who designed the strategy to develop the first treatment for HIV/AIDS and is now chair and president of consulting group ACCESS Health International
We are going back to a period at the beginning of my life, when antibiotics were just coming in–at the end of WWII–for civilian use. Penicillin had been discovered.
But before that, when we were building our railroads, when we were building our cities, we lived with the possibility that tomorrow will not come. Everybody knew that an infection could spell death. We are back to that era.
It’s something that many of us predicted: “There would come a time, there would come a disease that would take us back to the pre-antibiotic days.”
The world doesn’t end. Your world may end … but mankind goes on. We built the world at a time before vaccines and antibiotics. So we will prevail. But we will pay a price.
sense of fairness
A Top Immunologist on Why Coronavirus Is Killing More African-Americans
WSJ. April 22, 2020
All the other major vaccines we have—for measles, Ebola—have taken a minimum of seven years, and some as long as 40 years.
The race is on to find treatments for COVID-19. One of the most promising options being tested in Canada and around the world includes using antibodies from the blood plasma of recovered patients to help others fight the disease. The Agenda discusses the trial, as well as what is known about building immunity to the virus.